Please try another search
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company was incorporated in 1987 and is based in Melbourne, Australia.
Name | Age | Since | Title |
---|---|---|---|
Bruce Thompson | - | 2018 | Chairman of the Medical & Scientific Advisory Board |
Nicholas Smedley | - | 2019 | Executive Chairman |
Marjan Mikel | - | 2019 | CEO, MD & Executive Director |
Stephen Selinger | - | 2023 | Member of Medical Advisory Board |
Gerard J. Criner | - | 2023 | Member of Medical Advisory Board |
Tom Takubo | - | 2023 | Non-Executive Director |
Jonathan Hovda | - | 2023 | Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review